FWMNX
Price
$17.23
Change
-$0.53 (-2.98%)
Updated
Dec 18 closing price
FXAIX
Price
$204.50
Change
-$6.21 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

FWMNX vs FXAIX

Header iconFWMNX vs FXAIX Comparison
Open Charts FWMNX vs FXAIXBanner chart's image
Fidelity Advisor Women's Leadership I
Price$17.23
Change-$0.53 (-2.98%)
VolumeN/A
CapitalizationN/A
Fidelity 500 Index
Price$204.50
Change-$6.21 (-2.95%)
VolumeN/A
CapitalizationN/A
FWMNX vs FXAIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FWMNX vs. FXAIX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FWMNX is a Buy and FXAIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 632B vs. FWMNX (156M). FXAIX pays higher dividends than FWMNX: FXAIX (1.31) vs FWMNX (0.60). FWMNX was incepted earlier than FXAIX: FWMNX (6 years) vs FXAIX (14 years). FWMNX is a more actively managed with annual turnover of: 22.00 vs. FXAIX (3.00). FWMNX (0) and FXAIX (0) have matching initial minimum investment requirements. FXAIX annual gain was more profitable for investors over the last year : 29.40 vs. FWMNX (18.36). FXAIX return over 5 years is better than : 104.23 vs. FWMNX (66.56).
FWMNXFXAIXFWMNX / FXAIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years14 years-
Gain YTD16.94128.55059%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets156M632B0%
Annual Yield % from dividends0.601.3146%
Returns for 1 year18.3629.4062%
Returns for 3 years17.4137.1447%
Returns for 5 years66.56104.2364%
Returns for 10 yearsN/A217.91-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JNPR37.660.06
+0.16%
Juniper Networks
MRIN1.98N/A
N/A
Marin Software
TIPT21.21-0.24
-1.12%
Tiptree
CAKE50.39-0.97
-1.89%
Cheesecake Factory
GALT2.12-0.19
-8.23%
Galectin Therapeutics